13F Filings History of OPPENHEIMER ASSET MANAGEMENT INC.

Latest 13F report
Q4 2025 - 02 Feb 2026
Value $
$8,133,216,587
Signature - Title
Svetlana Milina - Managing Director
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by OPPENHEIMER ASSET MANAGEMENT INC.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. OPPENHEIMER ASSET MANAGEMENT INC. reported 1063 stock holdings with total value $8,133,216,587 as of Q4 2025. Top holdings included MSFT, BIL, NVDA, GBIL, and JPM.

Notify me when OPPENHEIMER ASSET MANAGEMENT INC. files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value

List of Other Managers Reporting for OPPENHEIMER ASSET MANAGEMENT INC.:

Name Holdings Value Location File Number
ALKEON CAPITAL MANAGEMENT LLC $22,870,342,819 New York, NY 028-10451
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 1,063 $8,133,216,587 +$592,110,882 -$1,546,842,111 -$954,731,229 MSFT, BIL, NVDA, GBIL, JPM 13F-HR 30 Jan 2026, 19:23
Q3 2025 1,154 $9,091,621,557 +$465,883,752 -$540,872,254 -$74,988,502 MSFT, BIL, NVDA, AMZN, JPM 13F-HR 05 Nov 2025, 21:52
Q2 2025 1,156 $8,719,429,957 +$621,431,015 -$543,141,956 +$78,289,059 MSFT, BIL, AMZN, V, NVDA 13F-HR 31 Jul 2025, 16:57
Q1 2025 1,121 $8,058,078,881 +$599,933,198 -$576,971,339 +$22,961,859 MSFT, BIL, AMZN, V, GBIL 13F-HR 22 Apr 2025, 21:12
Q4 2024 1,152 $8,227,089,647 +$466,711,495 -$487,119,399 -$20,407,904 MSFT, AMZN, BIL, JPM, AAPL 13F-HR 04 Feb 2025, 19:34
Q3 2024 1,159 $8,306,546,658 +$542,544,638 -$462,352,801 +$80,191,837 MSFT, BIL, AMZN, GBIL, AAPL 13F-HR 05 Nov 2024, 13:40
Q2 2024 1,149 $7,828,112,329 +$1,339,567,136 -$167,354,384 +$1,172,212,752 MSFT, AMZN, BIL, JPM, V 13F-HR 08 Aug 2024, 17:14
Q1 2024 1,108 $6,824,681,621 +$259,621,980 -$1,177,552,500 -$917,930,520 MSFT, BIL, AMZN, GBIL, JPM 13F-HR 06 May 2024, 21:46
Q4 2023 1,139 $7,187,825,607 +$457,507,877 -$456,855,927 +$651,950 MSFT, BIL, AMZN, JPM, V 13F-HR 13 Feb 2024, 15:13
Q3 2023 1,126 $6,516,449,438 +$314,688,254 -$287,302,415 +$27,385,839 MSFT, BIL, AMZN, JPM, V 13F-HR 07 Nov 2023, 20:18
Q2 2023 1,134 $6,798,412,223 +$281,531,079 -$343,232,412 -$61,701,333 MSFT, BIL, AMZN, V, JPM 13F-HR 02 Aug 2023, 18:40
Q1 2023 1,127 $6,492,943,787 +$416,110,883 -$446,115,299 -$30,004,416 MSFT, BIL, AMZN, V, JPM 13F-HR 10 May 2023, 17:28
Q4 2022 1,142 $6,212,285,545 +$430,372,947 -$394,409,471 +$35,963,476 MSFT, BIL, CVX, JPM, JNJ 13F-HR 06 Feb 2023, 18:42
Q3 2022 1,167 $5,668,751,000 +$376,208,877 -$207,896,679 +$168,312,198 MSFT, BIL, AMZN, CVX, JNJ 13F-HR 14 Nov 2022, 08:31
Q2 2022 1,214 $5,967,734,000 +$398,710,155 -$287,380,507 +$111,329,648 MSFT, AMZN, BIL, CVX, V 13F-HR 08 Aug 2022, 17:05
Q1 2022 1,257 $7,044,429,000 +$466,765,654 -$498,989,425 -$32,223,771 MSFT, AMZN, BIL, V, CVX 13F-HR 11 May 2022, 18:49
Q4 2021 1,289 $7,541,787,000 +$399,342,738 -$291,689,982 +$107,652,756 MSFT, AMZN, BIL, JPM, CVX 13F-HR 01 Feb 2022, 21:31
Q3 2021 1,249 $7,032,347,000 +$435,113,782 -$354,980,525 +$80,133,257 MSFT, AMZN, BIL, JPM, META 13F-HR 12 Nov 2021, 09:49
Q2 2021 1,251 $7,022,118,000 +$402,667,926 -$246,969,095 +$155,698,831 MSFT, BIL, AMZN, JPM, META 13F-HR 02 Aug 2021, 21:16
Q1 2021 1,207 $6,452,603,000 +$492,572,427 -$406,064,161 +$86,508,266 MSFT, BIL, JPM, AMZN, META 13F-HR 17 May 2021, 16:09
Q4 2020 1,177 $5,988,610,000 +$372,663,106 -$252,762,764 +$119,900,342 MSFT, BIL, JPM, V, META 13F-HR 10 Feb 2021, 21:33
Q3 2020 1,126 $5,150,383,000 +$333,420,759 -$322,488,243 +$10,932,516 MSFT, BIL, META, V, AMZN 13F-HR 13 Nov 2020, 11:35
Q2 2020 1,107 $4,846,007,000 +$363,773,949 -$413,404,575 -$49,630,626 MSFT, BIL, V, JPM, JNJ 13F-HR 11 Aug 2020, 15:31
Q1 2020 1,553 $4,069,777,000 +$795,672,054 -$438,358,072 +$357,313,982 MSFT, BIL, JPM, JNJ, V 13F-HR 07 May 2020, 17:45
Q4 2019 1,673 $4,733,570,000 +$222,684,313 -$296,798,602 -$74,114,289 GBIL, BIL, MSFT, JPM, JNJ 13F-HR 06 Feb 2020, 19:09
Q3 2019 1,668 $4,501,541,000 +$247,558,730 -$275,677,111 -$28,118,381 GBIL, BIL, MSFT, JPM, JNJ 13F-HR 31 Oct 2019, 17:13
Q2 2019 1,698 $4,525,610,000 +$250,510,172 -$303,363,899 -$52,853,727 GBIL, MSFT, BIL, JPM, JNJ 13F-HR 09 Aug 2019, 14:42
Q1 2019 1,669 $4,451,571,000 +$339,903,279 -$398,441,413 -$58,538,134 GBIL, MSFT, BIL, JNJ, JPM 13F-HR 24 Apr 2019, 16:59
Q4 2018 1,708 $4,035,890,000 +$451,253,492 -$278,413,716 +$172,839,776 GBIL, MSFT, JPM, JNJ, BIL 13F-HR 30 Jan 2019, 09:20
Q3 2018 1,202 $4,513,548,000 +$498,059,993 -$325,203,148 +$172,856,845 GBIL, MSFT, JPM, JNJ, LBTYK 13F-HR 26 Oct 2018, 16:14
Q2 2018 1,189 $4,086,906,000 +$325,574,987 -$294,208,255 +$31,366,732 MSFT, JPM, JNJ, AAP, CSCO 13F-HR 10 Aug 2018, 12:05
Q1 2018 1,203 $3,986,249,000 +$557,134,766 -$460,655,946 +$96,478,820 MSFT, JPM, JNJ, AAP, BRKB 13F-HR 09 May 2018, 14:45
Q4 2017 1,224 $3,630,590,000 +$12,669 -$90,807,359 -$90,794,690 MSFT, JNJ, JPM, BRKB, CVX 13F-HR 07 Feb 2018, 08:31
Q3 2017 1,798 $3,849,313,000 +$327,403,165 -$227,968,956 +$99,434,209 MSFT, JNJ, JPM, BRKB, CVX 13F-HR 13 Nov 2017, 20:16
Q2 2017 1,809 $3,618,674,000 +$250,583,398 -$214,132,740 +$36,450,658 MSFT, JNJ, JPM, VOD, BRKB 13F-HR 09 Aug 2017, 11:51
Q1 2017 1,836 $3,510,150,000 +$3,509,946,574 $0 +$3,509,946,574 MSFT, JNJ, JPM, LBTYK, BRKB 13F-HR 15 May 2017, 11:21
Q4 2016 2 $194,000 +$123,000 $0 +$123,000 TIP, CTB 13F-HR 01 Feb 2017, 18:46
Q3 2016 1 $73,000 $0 -$4 -$4 TIP 13F-HR 07 Nov 2016, 09:21
Q2 2016 2 $73,004 $0 $0 $0 TIP, FLUIDIGM CORP DEL 13F-HR 08 Aug 2016, 14:49
Q1 2016 2 $75,000 $0 $0 $0 TIP, FLUIDIGM CORP DEL 13F-HR 20 Apr 2016, 19:26
Q4 2015 2 $73,000 +$4,000 -$17 +$3,983 TIP, FLUIDIGM CORP DEL 13F-HR 01 Feb 2016, 18:10
Q3 2015 2 $69,017 +$4 $0 +$4 TIP, PDL BIOPHARMA INC 13F-HR 12 Nov 2015, 18:35
Q2 2015 2 $70,013 +$13 $0 +$13 TIP, PDL BIOPHARMA INC 13F-HR 12 Aug 2015, 17:22
Q1 2015 1 $71,000 $0 -$12,051 -$12,051 TIP 13F-HR 30 Apr 2015, 19:41
Q4 2014 4 $82,051 +$51 $0 +$51 TIP, BAC, COLONY FINL INC, FLUIDIGM CORP DEL 13F-HR 04 Feb 2015, 18:44
Q3 2014 2 $81,000 $0 $0 $0 TIP, BAC 13F-HR 12 Nov 2014, 07:55
Q2 2014 2 $82,000 $0 $0 $0 TIP, BAC 13F-HR 13 Aug 2014, 18:28
Q1 2014 2 $82,000 $0 $0 $0 TIP, BAC 13F-HR 08 May 2014, 19:11
Q4 2013 2 $79,000 $0 $0 $0 TIP, BAC 13F-HR 11 Feb 2014, 18:22